All data are based on the daily closing price as of May 12, 2026
e
Eiken Chemical
4549.TSE
18.28 USD
-0.98
-5.09%
Overview
Last close
18.28 usd
Market cap
602.50M usd
52 week high
21.76 usd
52 week low
13.47 usd
Target price
13.33 usd
Valuation
P/E
25.8282
Forward P/E
8.7108
Price/Sales
2.4161
Price/Book Value
2.2986
Enterprise Value
627.70M usd
EV/Revenue
2.3986
EV/EBITDA
13.1577
Key financials
Revenue TTM
261.92M usd
Gross Profit TTM
103.81M usd
EBITDA TTM
34.27M usd
Earnings per Share
0.74 usd
Dividend
0.36 usd
Total assets
384.45M usd
Net debt
-18.65M usd
About
Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate specific antigens; and clinical chemistry tests to measure and analyze biological components in blood serum and urine. In addition, it sells reagents and devices of microbiological test for food poisoning bacteria and environmental inspection; and offers nucleic acid amplification method, as well as provides various types of automated analyzers. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was incorporated in 1939 and is headquartered in Tokyo, Japan.